Start with the route.
Then the treatment.

A medicine can be authorised without a particular service being ready to prescribe it. Work through the route in order: the medicine’s licensed use, the national recommendation, the local funded service, the clinical assessment and the individual prescription. Each answers a different question.

For oral Wegovy and Foundayo, authorisation alone does not establish NHS funding. The medicine pages link the relevant official announcements and current appraisal information.

Our four-nations guide separates the current arrangements. In England, an ICB helps organise local NHS services; other nations use their own organisations and pathways. Ask your GP which service is relevant and how a referral is made.

Oviva’s referral information is organised by local NHS area. Our service guide also explains regional Second Nature and Morelife examples. A named provider is not a guarantee of a named medicine.

• Which pathway is being considered, and why?
• What records or previous results are needed?
• Which service receives the referral?
• How will I know whether it is accepted?
• What support is available while I wait?
• Who will coordinate monitoring and ongoing care?

Use our appointment preparation guide to organise your notes.

Understand both the complete cost and the clinical handover. A first-order offer may differ from repeat pricing. Med Easy uses Monj, iGovy, Ogovy and Dayo as its specialist price references.

Read how private and NHS care fit together before assuming prescribing or follow-up will transfer.